| Lactate shuttles in neuroenergetics—homeostasis, allostasis and beyond S Mason Frontiers in neuroscience 11, 43, 2017 | 206 | 2017 |
| A diagnostic biomarker profile for fibromyalgia syndrome based on an NMR metabolomics study of selected patients and controls BG Malatji, H Meyer, S Mason, UFH Engelke, RA Wevers, M Van Reenen, ... BMC neurology 17, 1-15, 2017 | 83 | 2017 |
| Uncovering the metabolic response of abalone (Haliotis midae) to environmental hypoxia through metabolomics L Venter, DT Loots, LJ Mienie, PJ Jansen van Rensburg, S Mason, ... Metabolomics 14, 1-12, 2018 | 60 | 2018 |
| A hypothetical astrocyte–microglia lactate shuttle derived from a 1H NMR metabolomics analysis of cerebrospinal fluid from a cohort of South African children with … S Mason, AM van Furth, LJ Mienie, UFH Engelke, RA Wevers, ... Metabolomics 11, 822-837, 2015 | 59 | 2015 |
| The GC–MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology BG Malatji, S Mason, LJ Mienie, RA Wevers, H Meyer, M Van Reenen, ... Metabolomics 15, 1-13, 2019 | 43 | 2019 |
| Metabolomics reveals the depletion of intracellular metabolites in HepG2 cells after treatment with gold nanoparticles JZ Lindeque, A Matthyser, S Mason, R Louw, CJF Taute Nanotoxicology 12 (3), 251-262, 2018 | 41 | 2018 |
| Facile immobilization of glucose oxidase onto gold nanostars with enhanced binding affinity and optimal function M Moses Phiri, D Wingrove Mulder, S Mason, B Christiaan Vorster Royal Society open science 6 (5), 190205, 2019 | 35 | 2019 |
| Disclosure of a putative biosignature for respiratory chain disorders through a metabolomics approach I Smuts, FH Van der Westhuizen, R Louw, LJ Mienie, UFH Engelke, ... Metabolomics 9, 379-391, 2013 | 34 | 2013 |
| Cerebrospinal fluid in tuberculous meningitis exhibits only the L-enantiomer of lactic acid S Mason, CJ Reinecke, W Kulik, A Van Cruchten, R Solomons, ... BMC Infectious Diseases 16, 1-6, 2016 | 29 | 2016 |
| A urinary biosignature for mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes (MELAS) K Esterhuizen, JZ Lindeque, S Mason, FH Van der Westhuizen, ... Mitochondrion 45, 38-45, 2019 | 28 | 2019 |
| Metabolomics of Ndufs4−/− skeletal muscle: Adaptive mechanisms converge at the ubiquinone-cycle K Terburgh, Z Lindeque, S Mason, F Van der Westhuizen, R Louw Biochimica et biophysica acta (BBA)-molecular basis of disease 1865 (1), 98-106, 2019 | 28 | 2019 |
| Cerebrospinal fluid amino acid profiling of pediatric cases with tuberculous meningitis S Mason, CJ Reinecke, R Solomons Frontiers in Neuroscience 11, 534, 2017 | 28 | 2017 |
| The cross-tissue metabolic response of abalone (Haliotis midae) to functional hypoxia L Venter, DT Loots, LJ Mienie, PJ Jansen van Rensburg, S Mason, ... Biology Open 7 (3), bio031070, 2018 | 25 | 2018 |
| Contribution towards a metabolite profile of the detoxification of benzoic acid through glycine conjugation: an intervention study C Irwin, M Van Reenen, S Mason, LJ Mienie, JA Westerhuis, CJ Reinecke Plos one 11 (12), e0167309, 2016 | 25 | 2016 |
| The 1H-NMR-based metabolite profile of acute alcohol consumption: A metabolomics intervention study C Irwin, M Van Reenen, S Mason, LJ Mienie, RA Wevers, JA Westerhuis, ... PLoS One 13 (5), e0196850, 2018 | 23 | 2018 |
| A putative urinary biosignature for diagnosis and follow-up of tuberculous meningitis in children: outcome of a metabolomics study disclosing host–pathogen responses S Mason, AMT van Furth, R Solomons, RA Wevers, M van Reenen, ... Metabolomics 12, 1-16, 2016 | 22 | 2016 |
| Miniaturized 1H-NMR method for analyzing limited-quantity samples applied to a mouse model of Leigh disease S Mason, K Terburgh, R Louw Metabolomics 14, 1-12, 2018 | 21 | 2018 |
| GC–MS-based urinary organic acid profiling reveals multiple dysregulated metabolic pathways following experimental acute alcohol consumption C Irwin, LJ Mienie, RA Wevers, S Mason, JA Westerhuis, M Van Reenen, ... Scientific Reports 8 (1), 5775, 2018 | 20 | 2018 |
| Tuberculous granuloma: emerging insights from proteomics and metabolomics AR Sholeye, AA Williams, DT Loots, AM Tutu van Furth, M van der Kuip, ... Frontiers in Neurology 13, 804838, 2022 | 19 | 2022 |
| One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m. 3243A> G mutation K Esterhuizen, JZ Lindeque, S Mason, FH van der Westhuizen, ... Metabolomics 17, 1-16, 2021 | 18 | 2021 |
